Engineering services firm out of Quebec. Good management that have grown organically and through acquisitions through the years. Nice mix between government and private contracts. Well positioned for any economic rebound. Expect 6% yield to be maintained after conversion Jan 1.

Primarily a generic drug manufacturer. Market has overreacted with the challenge it is facing with from a competitor on one of its branded drugs. 1.5% yield.

Have both fixed line and wireless but the wireless mix is going to be more significant going forward. Also completed an acquisition in Brazil that is expected to be accretive of earnings next year. 7.4% dividend.

(A Top Pick Aug 25/09. Down 3.12%.) Ran into some problems with some product recalls but it is still etched in the cheap.

(A Top Pick Aug 25/09. Up 8.23%.) Strong dividend yield of over 6%. Still likes.

Good wireless exposure and growth prospects but concerned it is getting a little too high but that is 15%-20% away. 4.5% yield.

Just reported and earnings were uninspiring but is reflective of the economic climate. Does better when people are consuming the high-end spirits. Solid dividend and keep raising it. 4.4% dividend.